Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Subscribe to see Prellis Biologics, Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Prellis Biologics, Inc is a biotechnology company headquartered in United States. Its most recent funding round, Series C, raised $35M in August 2022. Xcout tracks 9 named people at Prellis Biologics, Inc, including Mike Nohaile (Chief Executive Officer).
3 more named people on record for Prellis Biologics, Inc, with roles, board committees and tenure — see the full roster →
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $35M | — | |
| SEC Form D filing | $17M | — | |
| Series B | $14.5M | — | |
| SEC Form D filing | $19.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Prellis Biologics, Inc's closest competitors — see the full list of competitors and alternatives →
Aikium is a biotechnology company headquartered in Berkeley, California, that integrates deep learning with ultra-large-scale wet lab experimentation to advance protein therapeutics.
BigHat Biosciences, Inc. is a for-profit biotechnology company located in California. The firm leverages machine learning and synthetic biology to design next-generation antibody therapies.
immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
PostEra is an AI-first biotechnology company utilizing its proprietary Proton platform for medicinal chemistry to discover and develop new medicines for patients. The company operates out of Boston and Cambridge, Massachusetts.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Prellis Biologics, Inc? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.